StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Avenue Therapeutics's total assets was $1.98M at Jun 30, 2026. For fiscal 2025 it was $2.93M, up 9.7% from the year before. The highest annual figure on record is $22.17M in fiscal 2017.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.93M+9.7%
FY2024Dec 31, 2024$2.67M+44.4%
FY2023Dec 31, 2023$1.85M-73.0%
FY2022Dec 31, 2022$6.85M+72.9%
FY2021Dec 31, 2021$3.96M+22.0%
FY2020Dec 31, 2020$3.25M-63.6%
FY2019Dec 31, 2019$8.92M+97.0%
FY2018Dec 31, 2018$4.53M-79.6%
FY2017Dec 31, 2017$22.17M+11153.8%
FY2016Dec 31, 2016$197.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.98M-52.5%
Q1 FY2026Mar 31, 2026$2.47M-31.3%
Q4 FY2025Dec 31, 2025$2.93M+9.7%
Q3 FY2025Sep 30, 2025$3.73M+41.9%
Q2 FY2025Jun 30, 2025$4.16M-16.6%
Q1 FY2025Mar 31, 2025$3.59M+8.6%
Q4 FY2024Dec 31, 2024$2.67M+44.4%
Q3 FY2024Sep 30, 2024$2.63M+422.9%
Q2 FY2024Jun 30, 2024$4.99M+199.4%
Q1 FY2024Mar 31, 2024$3.31M-60.8%
Q4 FY2023Dec 31, 2023$1.85M-73.0%
Q3 FY2023Sep 30, 2023$502.00K-12.7%
Q2 FY2023Jun 30, 2023$1.67M+65.8%
Q1 FY2023Mar 31, 2023$8.45M+331.9%
Q4 FY2022Dec 31, 2022$6.85M+72.9%
Q3 FY2022Sep 30, 2022$575.00K-16.4%
Q2 FY2022Jun 30, 2022$1.01M-15.6%
Q1 FY2022Mar 31, 2022$1.96M+0.6%
Q4 FY2021Dec 31, 2021$3.96M+22.0%
Q3 FY2021Sep 30, 2021$688.00K-84.2%
Q2 FY2021Jun 30, 2021$1.19M-77.7%
Q1 FY2021Mar 31, 2021$1.94M-71.0%
Q4 FY2020Dec 31, 2020$3.25M-63.6%
Q3 FY2020Sep 30, 2020$4.35M-68.6%
Q2 FY2020Jun 30, 2020$5.33M-66.0%
Q1 FY2020Mar 31, 2020$6.70M-77.5%
Q4 FY2019Dec 31, 2019$8.92M+97.0%
Q3 FY2019Sep 30, 2019$13.88M+163.7%
Q2 FY2019Jun 30, 2019$15.68M+66.1%
Q1 FY2019Mar 31, 2019$29.76M+94.9%
Q4 FY2018Dec 31, 2018$4.53M-79.6%
Q3 FY2018Sep 30, 2018$5.26M-79.9%
Q2 FY2018Jun 30, 2018$9.44M-72.8%
Q1 FY2018Mar 31, 2018$15.27M+7652.8%
Q4 FY2017Dec 31, 2017$22.17M–
Q3 FY2017Sep 30, 2017$26.18M–
Q2 FY2017Jun 30, 2017$34.71M–
Q4 FY2016Dec 31, 2016$197.00K–

More Avenue Therapeutics figures

See a number that looks wrong?